SBRT Gains Support for Prostate Cancer: 3 Examples

Advances in prostate cancer research over recent years have contributed to a growing amount of support for stereotactic body radiation therapy (SBRT) as a treatment option for prostate cancer.

Below is an overview of some key milestones in SBRT prostate cancer research from world-renowned cancer organizations and researchers.

  • Prostate Cancer Research Study – Led by radiation oncologist Dr. Alan Katz and one of the largest of its kind, this study published in 2013 evaluated hundreds of prostate cancer patients who were treated with SBRT. The study followed 304 patients for an average of five to six years post-treatment and found that 97 percent of patients with low-risk and 90.7 percent of patients with intermediate-risk prostate cancer remained cancer-free throughout that time. The treatment was also shown to be minimally harmful, produced low levels of toxicity and reduced many common side effects. Read more about the study and results here.
  • ASTRO ModelÊPolicyÊUpdate – In 2013, the American Society for Radiation Oncology updated its position on the use of SBRT for prostate cancer. ASTRO published a model coverage policy that helps insurance companies provide insurance benefits to men for prostate cancer treatment.
  • NCCN Guidelines UpdateÊ In January 2014, the National Comprehensive Cancer Network (NCCN) updated its Clinical Practice Guidelines in Oncology® to include SBRT as a treatment option for prostate cancer. Developed and updated annually by nearly 950 clinical professionals, the guidelines help individuals involved in cancer care, including physicians, nurses, patients and their families, with the decision-making process intended to advance the fight against cancer.

CyberKnife Center of Chicago treats prostate cancer with SBRT using highly advanced CyberKnife®Êtechnology. To learn more about our treatment method, click here.

This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.

Follow Us